Literature DB >> 8103360

Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group.

C Ohmann1, D H Wittmann, H Wacha.   

Abstract

OBJECTIVE: To assess the accuracy of the APACHE II score, the Mannheim Peritonitis Index (MPI), and the Peritonitis Index Altona (PIA) II in the prediction of outcome of patients with peritonitis.
DESIGN: Prospective, multicentre study.
SETTING: 12 Departments of Surgery in Europe.
SUBJECTS: 271 Patients with peritonitis confirmed at laparatomy.
INTERVENTIONS: Computation of the three scores on one set of data for each patient. MAIN OUTCOME MEASURES: The ability to predict death or survival within 30 days of operation with each of the three scores. The prediction were evaluated according to the following criteria: discriminatory ability (areas under the receiver-operator characteristic (ROC) curves relating sensitivity to specificity); sharpness (level of confidence that was associated with a prediction); and reliability (agreement between predicted and observed mortality within equidistant intervals on the scale).
RESULTS: APACHE II was superior to both the MPI and PIA II in its discriminatory ability and reliability, but the MPI and PIA II made more "sharp" predictions.
CONCLUSIONS: None of the three scores is of any use for predicting the outcome for individual patients. APACHE II is the current standard for assessing the severity of peritonitis.

Entities:  

Mesh:

Year:  1993        PMID: 8103360

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  22 in total

Review 1.  [Relaparotomy in secondary peritonitis Planned relaparotomy or relaparotomy on demand?].

Authors:  B Lamme; C W Mahler; J W O van Till; O van Ruler; D J Gouma; M A Boermeester
Journal:  Chirurg       Date:  2005-09       Impact factor: 0.955

Review 2.  Secondary peritonitis: principles of diagnosis and intervention.

Authors:  James T Ross; Michael A Matthay; Hobart W Harris
Journal:  BMJ       Date:  2018-06-18

3.  Organ dysfunction and long term outcome in secondary peritonitis.

Authors:  M Hynninen; J Wennervirta; A Leppäniemi; V Pettilä
Journal:  Langenbecks Arch Surg       Date:  2007-03-20       Impact factor: 3.445

4.  Prognostic factors of the mortality of postoperative intraabdominal infections.

Authors:  N Torer; K Yorganci; D Elker; I Sayek
Journal:  Infection       Date:  2010-08       Impact factor: 3.553

5.  Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.

Authors:  J S Solomkin; S E Wilson; N V Christou; O D Rotstein; E P Dellinger; R S Bennion; R Pak; K Tack
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Intrarectal negative pressure system in the management of open abdomen with colorectal fistula: A case report.

Authors:  Fahri Yetişir; A Ebru Salman; Ruslan Mamedov; Mustafa Aksoy; Abdussamet Yalcin; Cüneyt Kayaalp
Journal:  Int J Surg Case Rep       Date:  2014-01-23

7.  Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections.

Authors:  J A Passarell; A K Meagher; K Liolios; B B Cirincione; S A Van Wart; T Babinchak; E J Ellis-Grosse; P G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

8.  Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis.

Authors:  Peter Panhofer; Barbara Izay; Markus Riedl; Veronika Ferenc; Martin Ploder; Raimund Jakesz; Peter Götzinger
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

9.  Scoring Systems for Outcome Prediction of Patients with Perforation Peritonitis.

Authors:  Murugappan Nachiappan; Manjusha Madhusudhan Litake
Journal:  J Clin Diagn Res       Date:  2016-03-01

10.  Survival after intestinal perforation: can it be predicted?

Authors:  Celestine S Tung; Charlotte C Sun; Matthew P Schlumbrecht; Larissa A Meyer; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2009-09-18       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.